Natco Pharma Share Dividend– The Board of Directors of Natco Medicines Company in an interview on Wednesday announced an interim dividend of Rs 1.50 per share for the financial year 2024-25.
Its all out income declined by 18.1% to ₹6,511 crore as against ₹7,956 crore in the earlier year. The organization’s profit before interest, expense, deterioration and amortization (EBITDA) declined by 29.4% to ₹2,151 crore as against ₹3,051 crore in the earlier year. Its EBITDA edge declined to 33% from 38.3% in the earlier year. Portions of Natco Pharma exchanged lower for the fifth back to back day on Thursday, February 13. The stock has declined 25.2% in the last five exchanging meetings. The stock opened Thursday’s exchanging meeting lower by 14.6% at ₹1,039.1. It then fell 18.5% to hit an intraday low of ₹992.15 per share. At 10.05 am, the stock was exchanging 17.62% lower at ₹1,004 per share. It has declined 31.87% over the most recent a half year. Likewise read: PFC offers might reach ₹660 as examiners foresee up to 75% potential gain
Natco Pharma Share Dividend This Pharma Stock fell badly after quarterly results
Natco Pharma Share Dividend A major factor behind the revenue decline is the decline in the blend formulation business, which is the company’s biggest revenue-generating segment. In the December quarter, revenue from formulations was almost half at ₹285.8 crore, compared to ₹605.6 crore in the same quarter a year ago. However, the company’s domestic formulation revenue was largely stable at ₹961 crore as against ₹994 crore in the same quarter last year.
